Skip to main content
. 2023 Jul 7;12(13):4537. doi: 10.3390/jcm12134537

Table 1.

Examples of promising tumoral PET radiotracers under investigation.

Targets Radiopharmaceuticals References
PD-L1
[64Cu]-NOTA-PD-L1 [79]
[89Zr]-atezolizumab [82]
EGFR
[89Zr]-cetuximab [100]
[89Zr]-trastuzumab [117]
[64Cu]-DOTA-trastuzumab [122]
HDAC
[11C]-Martinostat [127]
Estrogen receptor
[18F]-FES [129]
Tissue factor
[64Cu]-NOTA-ALT-836-Fab [161]
[18F]-ASIS [166]
Mucin 1
MUC1-FA-[18F] SFB [140]
CD146
[52Mn]-DOTA-YY146 [170]
[89Zr]-Df-YY146 [170]
[64Cu]-YY146 [170]
Trop 2
[89Zr]-DFO-AF650 [172]
Nectin 4
[68Ga]-N188 [173]